Disease-modifying therapy for HIV-related distal symmetrical polyneuropathy (including antiretroviral toxic neuropathy)
- 29 August 2020
- journal article
- research article
- Published by Wiley in Emergencias
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Epidemiology of HIV-Related Neuropathy: A Systematic Literature ReviewAIDS Research and Human Retroviruses, 2012
- Peripheral neuropathy in HIV: prevalence and risk factorsAIDS, 2011
- Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevanceJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathyAnnals of Neurology, 2008
- Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neuronsAnnals of Neurology, 2003
- Neurotrophic factors as novel therapeutics for neuropathic painNature Reviews Drug Discovery, 2003
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-α nerve injectionNeuroReport, 1998
- Nature and incidence of peripheral nerve syndromes in HIV infection.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992